7NFW

Human 14-3-3 sigma in complex with human Estrogen Receptor alpha peptide

7NFW の概要

• エントリーDOI: 10.2210/pdb7nfw/pdb
• 関連するPDBエントリー: 4JC3
• 分子名称: 14-3-3 protein sigma, Estrogen receptor (3 entities in total)
• 機能のキーワード: signaling protein-peptide complex, protein binding
• 由来する生物種: Homo sapiens (Human); 詳細
• タンパク質・核酸の鎖数: 2
• 化学式量合計: 32055.53

構造登録者

Roversi, P.,Falcicchio, M.,Doveston, R. (登録日: 2021-02-08, 公開日: 2021-02-17, 最終更新日: 2024-10-23)

主引用文献

Falcicchio, M.,Ward, J.A.,Chothia, S.Y.,Basran, J.,Mohindra, A.,Macip, S.,Roversi, P.,Doveston, R.G.
Cooperative stabilisation of 14-3-3 sigma protein-protein interactions via covalent protein modification.
Chem Sci, 12:12985-12992, 2021

PubMed Abstract: 14-3-3 proteins are an important family of hub proteins that play important roles in many cellular processes a large network of interactions with partner proteins. Many of these protein-protein interactions (PPI) are implicated in human diseases such as cancer and neurodegeneration. The stabilisation of selected 14-3-3 PPIs using drug-like 'molecular glues' is a novel therapeutic strategy with high potential. However, the examples reported to date have a number of drawbacks in terms of selectivity and potency. Here, we report that WR-1065, the active species of the approved drug amifostine, covalently modifies 14-3-3σ at an isoform-unique cysteine residue, Cys38. This modification leads to isoform-specific stabilisation of two 14-3-3σ PPIs in a manner that is cooperative with a well characterised molecular glue, fusicoccin A. Our findings reveal a novel stabilisation mechanism for 14-3-3σ, an isoform with particular involvement in cancer pathways. This mechanism can be exploited to harness the enhanced potency conveyed by covalent drug molecules and dual ligand cooperativity. This is demonstrated in two cancer cell lines whereby the cooperative behaviour of fusicoccin A and WR-1065 leads to enhanced efficacy for inducing cell death and attenuating cell growth.

PubMed: 34745529
DOI: 10.1039/d1sc02120f

実験手法

X-RAY DIFFRACTION (1.19 Å)